These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27650925)

  • 1. Synthesis of a selective HDAC6 inhibitor active in neuroblasts.
    Zwick V; Simões-Pires CA; Nurisso A; Petit C; Dos Santos Passos C; Randazzo GM; Martinet N; Bertrand P; Cuendet M
    Bioorg Med Chem Lett; 2016 Oct; 26(20):4955-4959. PubMed ID: 27650925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4-phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells.
    Rodríguez-Fonseca RA; Sixto-López Y; Fragoso-Vázquez MJ; Flores-Mejía R; Cabrera-Pérez LC; Vázquez-Moctezuma I; Rosales-Hernández MC; Bello M; Martínez-Archundia M; Trujillo-Ferrara JG; Becerra-Martínez E; Correa-Basurto J
    Anticancer Agents Med Chem; 2017; 17(10):1441-1454. PubMed ID: 28044941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137).
    Simões-Pires CA; Bertrand P; Cuendet M
    Expert Opin Ther Pat; 2017 Mar; 27(3):229-236. PubMed ID: 28092474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Thiazolidinedione-Based HDAC6 Inhibitors to Overcome Methamphetamine Addiction.
    Sharma C; Oh YJ; Park B; Lee S; Jeong CH; Lee S; Seo JH; Seo YH
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel class of anthraquinone-based HDAC6 inhibitors.
    Song Y; Lim J; Seo YH
    Eur J Med Chem; 2019 Feb; 164():263-272. PubMed ID: 30597327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel N-benzyltriazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.
    Kong SJ; Nam G; Boggu PR; Park GM; Kang JE; Park HJ; Jung YH
    Bioorg Med Chem; 2023 Feb; 79():117154. PubMed ID: 36645952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors.
    Senger J; Melesina J; Marek M; Romier C; Oehme I; Witt O; Sippl W; Jung M
    J Med Chem; 2016 Feb; 59(4):1545-55. PubMed ID: 26653328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity.
    Yoo J; Kim SJ; Son D; Seo H; Baek SY; Maeng CY; Lee C; Kim IS; Jung YH; Lee SM; Park HJ
    Eur J Med Chem; 2016 Jun; 116():126-135. PubMed ID: 27060764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel aminotetralin class of HDAC6 and HDAC8 selective inhibitors.
    Tang G; Wong JC; Zhang W; Wang Z; Zhang N; Peng Z; Zhang Z; Rong Y; Li S; Zhang M; Yu L; Feng T; Zhang X; Wu X; Wu JZ; Chen L
    J Med Chem; 2014 Oct; 57(19):8026-34. PubMed ID: 25238284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors.
    Goracci L; Deschamps N; Randazzo GM; Petit C; Dos Santos Passos C; Carrupt PA; Simões-Pires C; Nurisso A
    Sci Rep; 2016 Jul; 6():29086. PubMed ID: 27404291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform.
    Blackburn C; Barrett C; Chin J; Garcia K; Gigstad K; Gould A; Gutierrez J; Harrison S; Hoar K; Lynch C; Rowland RS; Tsu C; Ringeling J; Xu H
    J Med Chem; 2013 Sep; 56(18):7201-11. PubMed ID: 23964961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and therapeutic implications of selective histone deacetylase 6 inhibitors.
    Kalin JH; Bergman JA
    J Med Chem; 2013 Aug; 56(16):6297-313. PubMed ID: 23627282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.
    Yu CW; Chang PT; Hsin LW; Chern JW
    J Med Chem; 2013 Sep; 56(17):6775-91. PubMed ID: 23905680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of a series of CNS penetrant HDAC inhibitors structurally derived from amyloid-β probes.
    Choi MA; Park SY; Chae HY; Song Y; Sharma C; Seo YH
    Sci Rep; 2019 Sep; 9(1):13187. PubMed ID: 31515509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease.
    Batchu SN; Brijmohan AS; Advani A
    Clin Sci (Lond); 2016 Jun; 130(12):987-1003. PubMed ID: 27154743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors.
    Jadhavar PS; Ramachandran SA; Riquelme E; Gupta A; Quinn KP; Shivakumar D; Ray S; Zende D; Nayak AK; Miglani SK; Sathe BD; Raja M; Farias O; Alfaro I; Belmar S; Guerrero J; Bernales S; Chakravarty S; Hung DT; Lindquist JN; Rai R
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5222-5228. PubMed ID: 27717544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity.
    Loeuillet C; Touquet B; Oury B; Eddaikra N; Pons JL; Guichou JF; Labesse G; Sereno D
    Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):59-66. PubMed ID: 29414107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS.
    Simões-Pires CA; Zwick V; Cretton S; Cuendet M
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors.
    Seo YJ; Kang Y; Muench L; Reid A; Caesar S; Jean L; Wagner F; Holson E; Haggarty SJ; Weiss P; King P; Carter P; Volkow ND; Fowler JS; Hooker JM; Kim SW
    ACS Chem Neurosci; 2014 Jul; 5(7):588-96. PubMed ID: 24780082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity.
    Gaisina IN; Tueckmantel W; Ugolkov A; Shen S; Hoffen J; Dubrovskyi O; Mazar A; Schoon RA; Billadeau D; Kozikowski AP
    ChemMedChem; 2016 Jan; 11(1):81-92. PubMed ID: 26592932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.